Clinical Trials Directory

Trials / Sponsors / Harmony Biosciences Management, Inc.

Harmony Biosciences Management, Inc.

Industry · 12 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 32026-03-16
Enrolling By InvitationA Study of Pitolisant in Participants With Prader-Willi Syndrome
Prader-Willi Syndrome
Phase 32025-08-20
CompletedDrug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
Drug Interaction
Phase 12025-06-06
CompletedA Study of HBS-201 (Pitolisant Delayed-release)
Narcolepsy
Phase 12025-05-21
RecruitingA Study of Pitolisant in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Phase 32024-05-28
CompletedA Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomni
Idiopathic Hypersomnia, Excessive Daytime Sleepiness
Phase 32022-08-19
CompletedA Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Phase 32022-05-25
RecruitingWAKIX® (Pitolisant) Pregnancy Registry
Pregnancy Related, Narcolepsy
—2021-08-24
CompletedSafety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients
Myotonic Dystrophy 1, Excessive Daytime Sleepiness
Phase 22021-06-28
Active Not RecruitingA Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Foll
Prader-Willi Syndrome
Phase 22020-12-09
CompletedOpen-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion
22Q11.2 Deletion Syndrome
Phase 22020-02-19
No Longer AvailableExpanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Dayt
Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy
——